ARENA, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 162
EU - Europa 56
AS - Asia 27
SA - Sud America 4
AF - Africa 3
Totale 252
Nazione #
US - Stati Uniti d'America 160
IT - Italia 17
IN - India 12
SE - Svezia 12
UA - Ucraina 12
SG - Singapore 8
CN - Cina 7
FI - Finlandia 6
AR - Argentina 4
TG - Togo 3
CA - Canada 2
DE - Germania 2
GB - Regno Unito 2
LU - Lussemburgo 2
BG - Bulgaria 1
CH - Svizzera 1
IE - Irlanda 1
Totale 252
Città #
Fairfield 27
Chandler 24
Ashburn 14
Houston 12
Wilmington 9
Princeton 7
Woodbridge 7
Plano 6
Singapore 6
Ann Arbor 5
Cambridge 5
Milan 5
Boston 4
Federal 4
Rome 4
Seattle 4
Jacksonville 3
Lomé 3
San Paolo di Civitate 3
Beijing 2
Esch-sur-Alzette 2
Hefei 2
Lawrence 2
Nanjing 2
Pescara 2
San Diego 2
Toronto 2
Bern 1
Dearborn 1
Des Moines 1
Dublin 1
Falls Church 1
Forest City 1
Indiana 1
Jinan 1
Marburg 1
Massa 1
Millbury 1
Norwalk 1
Sofia 1
Southend 1
Totale 182
Nome #
Epstein-Barr virus lytic cycle activation alters proteasome subunit expression in Burkitt's lymphoma cells 57
Inhibition of p38 MAP kinase pathway induces apoptosis and prevents Epstein Barr virus reactivation in Raji cells exposed to lytic cycle inducing compounds 57
ANTIVIRAL EFFECTS OF RESVERATROL ON EPSTEIN BARR VIRUS LATENT AND LYTIC INFECTION 42
Resveratrol Inhibits Proliferation and Survival of Epstein Barr Virus-Infected Burkitt's Lymphoma Cells Depending on Viral Latency Program 37
SILENZIAMENTO DELL’ ONCOGENE LMP1 DI EBV : EFFETTI SULLA INFEZIONE LATENTE E LITICA DEL VIRUS 33
EFFECTS OF RESVERATROL ON THE LATENT AND THE LYTIC PHASES OF EPSTEIN BARR VIRUS INFECTION 26
Totale 252
Categoria #
all - tutte 628
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 628


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202046 10 2 0 2 5 5 7 6 4 1 3 1
2020/202113 0 1 1 3 0 0 0 4 1 0 3 0
2021/202250 0 5 5 0 6 1 0 6 7 8 2 10
2022/202366 13 15 4 3 6 9 2 6 4 2 2 0
2023/202432 3 4 0 3 4 10 0 0 0 3 4 1
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 252